Free

Actions and Detail Panel

Free

Event Information

Share this event

Date and time

Location

Location

Online event

Event description
This waiver training course provides an overview of the medication buprenorphine prescribed for the treatment of opioid use disorder.

About this event

PCSS 8-Hour Full Day Waiver Training

Hosted by: Maryland Addiction Consultation Service (MACS)

Tuesday, February 8th, 2022

8:00 am - 5:15 pm

Free, Virtual CME Training with breakout sessions!

After registering on Eventbrite, you will receive a calendar invitation from Webex after 1-2 business days.  Please see below for new guidelines from PCSS on joining the virtual training!

Questions? 

Contact us at MACSTraining@som.umaryland.edu

New PCSS Virtual Waiver Training Procedures

  • All participants must have their video camera turned on for the training
  • Attendance will be taken at the beginning and end of the training

Full 8-Hour Course

The PCSS waiver training course provides an overview of the FDA-approved medication buprenorphine prescribed for the treatment of opioid use disorder (OUD). The course meets the required 8-hour training to prescribe buprenorphine for the treatment of OUD.

Upon completion of the training, providers will meet the requirement of the DATA 2000 to apply for a waiver to prescribe buprenorphine.

Physicians are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. Advance Practice Registered Nurses (APRNs) and Physician Assistants (PAs) complete the standardized buprenorphine waiver 8-hour training as well as an additional 16 hours of online training as established by the Comprehensive Addiction and Recovery Act (CARA) which can be found here: https://pcssnow.org/medications-for-opioid-use-disorder/ 

Providers who want to treat more than 30 patients at any one time must complete the waiver training course.

Objectives

At the conclusion of this activity participants should be able to:

  • Screen and identify patients with OUD and define evidence-based treatments
  • Discuss the pharmacology of opioids as it relates to treatment including the treatment of opioid use disorder (OUD) patients
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient
  • Explain the process of buprenorphine induction as well as stabilization and maintenance
  • Discuss other approved antagonist and agonist medications to treat OUD
  • Discuss basic office protocols including medical record documentation and confidentiality
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD
  • Apply for a waiver to begin treating patients with OUD. Please bring your DEA number and Medical State License Number to apply

Trainers: Eric Weintraub, MD, Aditi Ringwala, MD, and Avinash Ramprashad, MD

Event contact: Bridget Sweeney, Training Coordinator

MACSTraining@som.umaryland.edu

New HHS practice guidelines from the Department of Health and Human services make providing life-saving treatment for opioid use disorder easier. Find out more information here: https://bit.ly/3jergt9

Find out if you’re eligible to receive a $1,000 incentive for completing the DATA 2000 Waiver Training

Learn more about the MOM Model Provider Incentive Program for Maryland prescribers: https://bit.ly/3n2mrGN

Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the American Academy of Addiction Psychiatry and American Academy of Family Physicians. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Designation Statement: American Academy of Addiction Psychiatry designates this live course for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Designation Statement: American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider # 4008192. This program is approved for up to 8 Nursing Contact Hours.

PA Designation Statement:

American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

AAAP is the Data Sponsor for this waiver training. pcss@aaap.org

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


		PCSS 8-Hour Waiver Training image

		PCSS 8-Hour Waiver Training image

		PCSS 8-Hour Waiver Training image

Date and time

Location

Online event

{ _('Organizer Image')}

Organizer Maryland Addiction Consultation Service (MACS)

Organizer of PCSS 8-Hour Waiver Training

MACS provides support to prescribers and their practices in addressing the needs of their patients with substance use disorders and chronic pain management.

Save This Event

Event Saved